Table 3 Adjusted Prevalence Odds Ratios for Three Outcomes: Evaluation of a Potential Interaction between Elevated Antiphospholipid Antibody Titers (EAAT) and Systemic Lupus Erythematosus (SLE)
| Â | Outcomes | |||||
|---|---|---|---|---|---|---|
| Â | Preeclampsia or Eclampsia | Â | Placental Insufficiency | Â | Prolonged length of stay | Â |
Risk Factor Group | Odds Ratio* [95% CI†] | P-value | Odds Ratio‡ [95% CI†] | P-value | Odds Ratio§ [95% CI†] | P-value |
Has EAAT, and Has SLE (n = 5) | 33.14 [5.29, 207.61] | 0.0002 | 14.12 [1.58, 126.51] | 0.018 | 9.68 [1.57, 59.87] | 0.015 |
Has EAAT, No SLE (n = 83) | 2.12 [0.98, 4.63] | 0.058 | 4.06 [1.64, 10.03] | 0.0025 | 3.72 [2.38, 5.83] | < 0.0001 |
No EAAT, Has SLE (n = 126) | 3.29 [1.97, 5.52] | < 0.0001 | 4.61 [2.34, 9.09] | < 0.0001 | 3.69 [2.56, 5.31] | < 0.0001 |
No EAAT, and No SLE (n = 141,072) | 1 [Reference] | -- | 1 [Reference] | -- | 1 [Reference] | -- |